Monographie - Infliximab - Stabilis 4.0

Ultimele actualizari :
19/11/2024

Imunosupresor

Infliximab

Injectabil

colir

Stabilitatea in solutie

Stabilitatea in amestec

Factorii care influenteaza stabilitatea

Compatibilitate

Microunde

Bibliografie

pdf

Denumirea comerciala

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Flixabi	Belgia, Germania, Marea Britanie, Spania
Flixceli	Peru
Inflectra	Belgia, Canada, Elvetia, Germania, Islanda, Italia, Marea Britanie, Romania, Spania
Infliximab	Chilli
Remicade	Arabia Saudita, Argentina, Australia, Austria, Belgia, Canada, Chilli, Columbia, Danemarca, Ecuador, Elvetia, Emiratele Arabe Unite, Finlanda, Franta, Germania, Grecia, Iran, Irlanda, Islanda, Italia, Japonia, Luxemburg, Malaezia, Marea Britanie, Mexic, Norvegia, noua Zeelandă, Olanda, Peru, Polonia, Portugalia, Romania, Spania, SUA, Suedia, Tunisia, Turcia, Venezuela
Remsima	Argentina, Belgia, Canada, Chilli, Ecuador, Elvetia, Franta, Germania, Islanda, Italia, Marea Britanie, Norvegia, Peru, Romania, Spania, Turcia
Zessli	Belgia, Germania, Marea Britanie

Bibliografie

Injectabil

Bibliografie : Infliximab

	tip	publicare
754	Laborator	Infliximab (Remicade®) – Summary of Product Characteristics Merck Sharp & Dohme 2019
2296	Laborator	Témocilline (Negaban®) - Résumé des caractéristiques du produit Eumedica 2017
3137	ziar	Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS. Infliximab stability after reconstitution, dilution, and storage under refrigeration. Retina 2010 ; 30, 1: 81-84.
3317	poster	Guirao S, Paul M, Jaccoulet E, Morand K, Astier A. Stabilité de l'infliximab en solutions diluées. APHIF Congress 2009
3333	ziar	Ikeda R, Vermeulen L.C, Lau E, Jiang Z, Saha S, Reichelderfer M, Kolesar J.M. Stability of infliximab in polyvinyl chloride bags. Am J Health-Syst Pharm 2012 ; 69:1509-1512.
3825	ziar	Young B.L, Ali Khan M, Chapman T.J, Parry R,. Connolly M.A, Watts A.G. Evaluation of the physicochemical and functional stability of diluted REMSIMA(R) upon extended storage—A study compliant with NHS (UK) guidance. J Pharm Pract and Res 2015 ; 496: 421-431.
3924	ziar	Vieillard V, Astier A, Sauzay C, Paul M. One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C. Ann Pharm Fr 2016 ; 75, 1 : 17-29.
4003	ziar	Kim J, Chung J, Park S, Jung S, Kang D. Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab). EJHP 2017 ; 25, 3: 157-164.
4049	ziar	Tokhadze N, Chennell P, Le Basle Y, Sautou V. Stability of infliximab solutions in different temperature and dilution conditions. J Pharm Biomed Anal 2018 ; 150 : 386-395
4279	ziar	Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). Bio Drugs 2019 ; 33: 193–205.
4292	ziar	Vimpolsek M, Gottar-Guillier M, Rossy E. Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion. Drugs R D 2019 19: 127–140.

Mentions Légales